Author

Danièle Debruyne

Observed names: Correspondance Danièle Debruyne, Correspondence Danièle Debruyne, D DEBRUYNE, D Debruyne, D. DEBRUYNE, D. DeBruyne, D. Debruyne, DEBRUYNE, Danièle, Daniele Debruyne, Debruyne Danièle

Observed institutions: Centre National de la Recherche Scientifique, Ifremer, Inserm, Commissariat à l'Énergie Atomique et aux Énergies Alternatives, Normandie Université, Agence Nationale de Sécurité du Médicament et des Produits de Santé, Centre d'Exploration et de Recherche Médicale par Emission de Positons, Centre Hospitalier Universitaire de Caen Normandie, Laboratoire de Chimie Moléculaire et Thioorganique, Cyceron, Imagerie et Stratégies Thérapeutiques des Pathologies Cérébrales et Tumorales, Institut de Chimie Moléculaire de l'Université de Bourgogne, Imagerie et Stratégies Thérapeutiques pour les Cancers et Tissus cérébraux, Université de Caen Normandie

OpenAlex ID: A5111879707

Clinical Pharmacokinetics of Fluconazole

1993 · Danièle Debruyne, Jean-Philippe Ryckelynck · Clinical Pharmacokinetics · 259

Focus on cannabinoids and synthetic cannabinoids

2016 · R Le Boisselier, J Alexandre, et al. · Clinical Pharmacology & Therapeutics · 180

Clinical Pharmacokinetics of Fluconazole in Superficial and Systemic Mycoses

1997 · Danièle Debruyne · Clinical Pharmacokinetics · 151

Emerging drugs of abuse: current perspectives on synthetic cannabinoids

2015 · Daniele Debruyne, Reynald LE BOISSELIER · Substance Abuse and Rehabilitation · 124

PDF

Emerging drugs of abuse: current perspectives on substituted cathinones

2014 · Daniele Debruyne, Magalie Loilier, et al. · Substance Abuse and Rehabilitation · 107

PDF

Pharmacokinetics and pharmacodynamics of MD1003 (high-dose biotin) in the treatment of progressive multiple sclerosis

2015 · Laure Peyro Saint Paul, Danièle Debruyne, et al. · Expert Opinion on Drug Metabolism & Toxicology · 97

PET and SPECT Imaging of the NMDA Receptor System: An Overview of Radiotracer Development

2010 · F. Sobrio, G. Gilbert, et al. · Mini-Reviews in Medicinal Chemistry · 58

Pharmacokinetics of All-trans Retinoic Acid, 13-cis Retinoic Acid, and Fenretinide in Plasma and Brain of Rat

2000 · François Le Doze, Daniele Debruyne, et al. · Drug Metabolism and Disposition · 58

Substantial rise in sparteine metabolic ratio during haloperidol treatment.

1989 · LF Gram, D. Debruyne, et al. · British Journal of Clinical Pharmacology · 58

PDF

Clinical Pharmacokinetics of Ketoprofen After Single Intravenous Administration as a Bolus or Infusion

1987 · Danièle Debruyne, Bruno Hurault de Ligny, et al. · Clinical Pharmacokinetics · 51

Toxicity and death following recreational use of 2-pyrrolidino valerophenone

2013 · Celine Eiden, Olivier Mathieu, et al. · Clinical Toxicology · 48

Pharmacokinetics of Fluconazole in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

1990 · Danièle Debruyne, Jean-Philippe Ryckelynck, et al. · Clinical Pharmacokinetics · 46

Spectroscopie RMN du Carbone‐13 de Thiocétones Aliphatiques: Propanethione et Dérivés, Thiocétones Bicycliques et α Cyclopropaniques

1978 · Claude G. Andrieu, Danièle Debruyne, et al. · Organic Magnetic Resonance · 44

Short-term pharmacokinetics and brain distribution of mecamylamine as a preliminary to carbon-11 labeling for nicotinic receptor investigation

2003 · D. Debruyne, F. Sobrio, et al. · Journal of Pharmaceutical Sciences · 39

Plasma pharmacokinetics and metabolism of the benzodiazepine antagonist [11C] Ro 15-1788 (flumazenil) in baboon and human during positron emission tomography studies

1991 · D. Debruyne, P. Abadie, et al. · European Journal of Drug Metabolism and Pharmacokinetics · 38

Determination of Fluconazole in Biological Fluids by Capillary Column Gas Chromatography with a Nitrogen Detector

1988 · D. Debruyne, J.-P. Ryckelynck, et al. · Journal of Pharmaceutical Sciences · 36

Synthesis, evaluation and metabolic studies of radiotracers containing a 4-(4-[18F]-fluorobenzyl)piperidin-1-yl moiety for the PET imaging of NR2B NMDA receptors

2011 · Romain Labas, Gwénaëlle Gilbert, et al. · European Journal of Medicinal Chemistry · 31

Comparison of Five Benzodiazepine-Receptor Agonists on Buprenorphine-Induced μ-Opioid Receptor Regulation

2009 · Géraldine Poisnel, Martine Dhilly, et al. · Journal of Pharmacological Sciences · 31

PDF

Determination of Zolpidem and Zopiclone in Serum by Capillary Column Gas Chromatography

1991 · D. Debruyne, J. Lacotte, et al. · Journal of Pharmaceutical Sciences · 31

Interactions of buprenorphine and dipotassium clorazepate on anxiety and memory functions in the mouse

2006 · Véronique Lelong-Boulouard, Thomas Quentin, et al. · Drug and Alcohol Dependence · 28

Monitoring serum bupivaca�ne levels during arthroscopy

1985 · D. Debruyne, M. A. Moulin, et al. · European Journal of Clinical Pharmacology · 26

[11C]-MeJDTic: a novel radioligand for κ-opioid receptor positron emission tomography imaging

2008 · Géraldine Poisnel, Farhana Oueslati, et al. · Nuclear Medicine and Biology · 25

A comparison of methods for the separation of [11C]Ro 15-1788 (flumazenil) from its metabolites in the blood of rabbits, baboons and humans

1991 · L. Barre, D. Debruyne, et al. · International Journal of Radiation Applications and Instrumentation Part A Applied Radiation and Isotopes · 25

Treatment of Caffeine Intoxication by Exchange Transfusion in a Newborn

1987 · C. PERRIN, D. DEBRUYNE, et al. · Acta Paediatrica · 24

New Synthetic Drugs in Addictovigilance

2015 · François Chavant, Alexandra Boucher, et al. · Therapies · 23

PDF

Works count: 119

Citation count: 2,339

H-index: 24

I10-index: 58